South Africa Vaccines Market to 2032
Overview
The South Africa Vaccines Market is expected to reach a 372.71 USD Billion by 2032 and is projected to grow at a CAGR of 10.01% from 2025 to 2032.
Revenue, 2024 (USD Billion)
219.99
Forecast, 2032 (USD Billion)
372.71
CAGR, 2024 - 2032
10.01%
Report Coverage
South Africa
South Africa Vaccines Market 2018-2032 USD Billion
South Africa Vaccines Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 219.99 USD Billion
- Projected Market Size (2032): 372.71 USD Billion
- CAGR (2025-2032): 10.01%
Key Findings of South Africa Vaccines Market
- The South Africa Vaccines Market was valued at 219.99 USD Billion in 2024.
- The South Africa Vaccines Market is likely to grow at a CAGR of 10.01% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 198.34 USD Billion
- The fastest growing segment Influenza in Diseases Segment grew Fastest with a CAGR of 11.86% during the forecast period from 2024 to 2032.
South Africa Vaccines Market Scope
South Africa Vaccines Market Segmentation & Scope
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
Route of Administration
- Nasal
- Oral
- Injectable
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
South Africa Vaccines Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 219.99 USD Billion |
| Market Value in 2032 | 372.71 USD Billion |
| CAGR (2025-2032) | 10.01% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Route of Administration,Type,Composition,Age of Administration,Diseases,Kind |
Regional Insights:
-
Leading Market (2024-2032): South Africa, leading in terms of revenue 219.99 USD Billion in 2024
- Key Country: South Africa, leading in terms of revenue with value of 219.99 USD Billion in 2024.
Segments and Scope
-
South Africa Vaccines Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in South Africa Vaccines Market to 2032 with a revenue of 151.11 USD Billion in the year 2024.
- Retail Pharmacy is the Fastest growing segment in South Africa Vaccines Market to 2032 with a Growth rate of 9.53 % in forecast period 2025-2032.
-
South Africa Vaccines Market to 2032, By End User
- Community Hospitals is the largest segment in South Africa Vaccines Market to 2032 with a revenue of 136.28 USD Billion in the year 2024.
- Specialty Centres is the Fastest growing segment in South Africa Vaccines Market to 2032 with a Growth rate of 9.81 % in forecast period 2025-2032.
-
South Africa Vaccines Market to 2032, By Route of Administration
- Injectable is the largest segment in South Africa Vaccines Market to 2032 with a revenue of 198.34 USD Billion in the year 2024.
- Injectable is the Fastest growing segment in South Africa Vaccines Market to 2032 with a Growth rate of 10.20 % in forecast period 2025-2032.
-
South Africa Vaccines Market to 2032, By Type
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the largest segment in South Africa Vaccines Market to 2032 with a revenue of 87.49 USD Billion in the year 2024.
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the Fastest growing segment in South Africa Vaccines Market to 2032 with a Growth rate of 10.72 % in forecast period 2025-2032.
-
South Africa Vaccines Market to 2032, By Composition
- Combination Vaccines is the largest segment in South Africa Vaccines Market to 2032 with a revenue of 169.78 USD Billion in the year 2024.
- Combination Vaccines is the Fastest growing segment in South Africa Vaccines Market to 2032 with a Growth rate of 10.29 % in forecast period 2025-2032.
-
South Africa Vaccines Market to 2032, By Age of Administration
- Pediatric Vaccines is the largest segment in South Africa Vaccines Market to 2032 with a revenue of 129.32 USD Billion in the year 2024.
- Adult Vaccines is the Fastest growing segment in South Africa Vaccines Market to 2032 with a Growth rate of 9.77 % in forecast period 2025-2032.
-
South Africa Vaccines Market to 2032, By Diseases
- Pneumoccocal Disease is the largest segment in South Africa Vaccines Market to 2032 with a revenue of 35.63 USD Billion in the year 2024.
- Influenza is the Fastest growing segment in South Africa Vaccines Market to 2032 with a Growth rate of 11.16 % in forecast period 2025-2032.
-
South Africa Vaccines Market to 2032, By Kind
- Routine Vaccine is the largest segment in South Africa Vaccines Market to 2032 with a revenue of 148.92 USD Billion in the year 2024.
- Recommended Vaccines is the Fastest growing segment in South Africa Vaccines Market to 2032 with a Growth rate of 9.54 % in forecast period 2025-2032.
South Africa Vaccines Market Company Share Analysis
South Africa Vaccines Market Geographical Sales Distribution, 2018-2032 USD Billion
South Africa Vaccines Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Africa Vaccines Market is segmented based on Segmentation Distribution Channel,End User,Route of Administration,Type,Composition,Age of Administration,Diseases,Kind.
South Africa Vaccines Market was valued at USD 219.99(Revenue in USD Billion) in 2020.
South Africa Vaccines Market is projected to grow at a CAGR of 10.01% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the South Africa Vaccines Market, holding a largest market share of 198.34 USD Billion in 2024
Coming Soon....
South Africa Vaccines Market Scope
South Africa Vaccines Market Segmentation & Scope
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
Route of Administration
- Nasal
- Oral
- Injectable
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
Frequently Asked Questions
The South Africa Vaccines Market is segmented based on Segmentation Distribution Channel,End User,Route of Administration,Type,Composition,Age of Administration,Diseases,Kind.
South Africa Vaccines Market was valued at USD 219.99(Revenue in USD Billion) in 2020.
South Africa Vaccines Market is projected to grow at a CAGR of 10.01% during the forecast period of 2024 to 2032.
The estimated market value of the South Africa Vaccines Market for final year is USD 372.71 (USD Billion).
South Africa Vaccines Market Company Profiling
Frequently Asked Questions
The South Africa Vaccines Market is segmented based on Segmentation Distribution Channel,End User,Route of Administration,Type,Composition,Age of Administration,Diseases,Kind.
South Africa Vaccines Market was valued at USD 219.99(Revenue in USD Billion) in 2020.
South Africa Vaccines Market is projected to grow at a CAGR of 10.01% during the forecast period of 2024 to 2032.
The estimated market value of the South Africa Vaccines Market for final year is USD 372.71 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.